Novartis AG (NVS)
137.16
-0.32
(-0.23%)
USD |
NYSE |
Sep 11, 16:00
140.19
+3.03
(+2.21%)
Pre-Market: 05:30
Novartis Market Cap : 251.08B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 251.08B |
| September 10, 2026 | 251.66B |
| September 09, 2026 | 251.66B |
| September 08, 2026 | 252.07B |
| September 04, 2026 | 292.87B |
| September 03, 2026 | 298.54B |
| September 02, 2026 | 297.39B |
| September 01, 2026 | 295.18B |
| August 31, 2026 | 278.35B |
| August 28, 2026 | 281.56B |
| August 27, 2026 | 283.09B |
| August 26, 2026 | 288.38B |
| August 25, 2026 | 292.85B |
| August 24, 2026 | 289.26B |
| August 21, 2026 | 290.80B |
| August 20, 2026 | 286.00B |
| August 19, 2026 | 293.46B |
| August 18, 2026 | 282.91B |
| August 17, 2026 | 278.19B |
| August 14, 2026 | 276.19B |
| August 13, 2026 | 277.73B |
| August 12, 2026 | 278.83B |
| August 11, 2026 | 283.02B |
| August 10, 2026 | 287.01B |
| August 07, 2026 | 286.17B |
| Date | Value |
|---|---|
| August 06, 2026 | 282.29B |
| August 05, 2026 | 282.71B |
| August 04, 2026 | 280.57B |
| August 03, 2026 | 281.30B |
| July 31, 2026 | 285.84B |
| July 30, 2026 | 290.03B |
| July 29, 2026 | 290.75B |
| July 28, 2026 | 292.61B |
| July 27, 2026 | 285.77B |
| July 24, 2026 | 283.75B |
| July 23, 2026 | 285.82B |
| July 22, 2026 | 280.22B |
| July 21, 2026 | 281.67B |
| July 20, 2026 | 273.78B |
| July 17, 2026 | 281.47B |
| July 16, 2026 | 291.42B |
| July 15, 2026 | 287.74B |
| July 14, 2026 | 286.90B |
| July 13, 2026 | 292.64B |
| July 10, 2026 | 293.94B |
| July 09, 2026 | 295.03B |
| July 08, 2026 | 296.08B |
| July 07, 2026 | 299.63B |
| July 06, 2026 | 296.69B |
| July 02, 2026 | 305.10B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 291.21B |
| AstraZeneca PLC | 496.79B |
| GSK Plc | 97.35B |
| Johnson & Johnson | 639.58B |
| Eli Lilly & Co. | 1.050T |
Market Cap Related Metrics
| PE Ratio | 20.69 |
| PS Ratio | 4.818 |
| Price to Book Value | 6.044 |
| Price to Free Cash Flow | 17.61 |
| Price | 137.16 |
| Earnings Yield | 4.83% |
| Operating PE Ratio | 16.29 |
| Normalized PE Ratio | 19.28 |